Search Results - I. V. Fomin
- Showing 1 - 20 results of 28
- Go to Next Page
-
1
CHRONIC HEART FAILURE IN RUSSIAN FEDERATION: WHAT DO WE KNOW AND WHAT TO DO by I. V. Fomin
Published 2016-08-01The analysis is presented, of the three epidemiologic studies (EPOCHA-CHF, EPOCHA-Hospital-CHF, EPOCHA-Decompensation-CHF). In 16 years, prevalence of chronic heart failure (CHF) in Russia increased from 4,9% (1998) to 10,2% (2014), p=0,01. However, number of CHF patients with III-IV FC NYHA increas...
Get full text
Article -
2
Thiazide diuretics: 50 years of history or looking into the future by I. V. Fomin
Published 2010-08-01The history of thiazide diuretics’ use during the last 50 years is reviewed. The effects of thiazide diuretics on arterial hypertension treatment effectiveness, cardiovascular mortality and cardiovascular morbidity are discussed. In addition, their hemodynamic effects and safety profile are assessed...
Get full text
Article -
3
Choosing therapeutic tactics in pregnant women with chronic arterial hypertension: the priorities by N. G. Pivonova, I. V. Fomin
Published 2009-08-01Aim. To evaluate the pregnancy and delivery course, as well as fetal and newborn status, while achieving optimal blood pressure (BP) levels with different regimens of antihypertensive therapy (AHT) in pregnant women with chronic arterial hypertension (AH). Material and methods. Starting from Trimes...
Get full text
Article -
4
Contribution of the COVID-19 pandemic to the prognosis of patients with class III-IV heart failure by A. R. Vaisberg, I. V. Fomin, D. S. Polyakov, Yu. V. Omarova
Published 2022-04-01Aim. To study the survival of patients with New York Heart Association (NYHA) class IIIV heart failure (HF) after a coronavirus disease 2019 (COVID-19) and compare it with a group of similar patients without COVID-19, both during and before the pandemic.Material and methods. A sample of 810 patients...
Get full text
Article -
5
Carbohydrate metabolism disorders in patients with heart failure: data from the local registry by A. R. Vaisberg, E. I. Tarlovskaya, I. V. Fomin, D. S. Polyakov, Yu. V. Omarova
Published 2021-04-01Aim. To study the prevalence of carbohydrate metabolism disorders in patients with heart failure (HF) hospitalized in the city HF center.Material and methods. According to the local registry, the study sequentially included 183 patients (99 men and 84 women) hospitalized in the Nizhny Novgorod city...
Get full text
Article -
6
FORECASTING PRACTICES IN ACADEMIC IR: METHODOLOGICAL MAINSTREAM AND UNSOLVED PROBLEMS by I. V. Fomin, K. P. Kokarev, B. I. Ananyev, N. Yu. Silaev, A. A. Sushentsov, A. D. Chekov
Published 2019-01-01The article is devoted to the analysis of research tools that are dominant in international relations forecasting. The study is based on quantitative description of 160 prognostic articles from leading journals on international relations for the period from 2006 to 2015. An innovative typology of pr...
Get full text
Article -
7
MODERN APPROACHES TO THE DETERMINATION OF THE ANGLE OF TEETH INCLINATION IN THE DIAGNOSIS AND PLANNING OF ORTHODONTIC TREATMENT by V. V. Shkarin, D. A. Domenyuk, S. V. Dmitrienko, M. P. Porfiriadis, I. V. Fomin, V. A. Borodinа
Published 2018-05-01Aim. To conduct a comparative analysis of existing methods for measuring the angles of inclination of tooth and determining the torque of teeth with orthognathic occlusion.Materials and methods. Inclination angles were measured in 137 patients with physiological occlusion and the standard values of...
Get full text
Article -
8
Rationale and design of multicenter prospective observational study of types, GRAde, VariabilITY, associations and prognosis of orthostatic responses in Heart Failure (GRAVITY-HF) by E. V. Shlyakhto, S. V. Villevalde, A. E. Soloveva, N. E. Zvartau, M. Yu. Sitnikova, D. N. Fedorova, N. G. Vinogradova, I. V. Fomin
Published 2020-02-01Heart failure (HF) is one of the leading causes of adult mortality. Increased risk of death determines need for better understanding of the pathophysiological mechanisms, predictive risk stratification models and applicable methods to improve prognosis. One of the unfavorable prognostic factors may...
Get full text
Article -
9
VACCINATION AGAINST PNEUMOCOCCAL INFECTIONS IN RUSSIAN FEDERATION: SOCIAL AND PHARMACOECONOMIC ASPECTS by A. V. Rudakova, N. I. Briko, Yu. V. Lobzin, L. S. Namazova-Baranova, S. N. Avdeev, G. L. Ignatova, M. P. Kostinov, I. S. Koroleva, R. V. Polibin, I. V. Fomin
Published 2018-10-01Vaccination against pneumococcal infections by 13-valent conjugate vaccine (PCV13) can significantly reduce morbidity and mortality.The study has been aimed to evaluate the social and pharmacoeconomic aspects of PCV13 vaccination of 65-year-old patients with various risks of pneumococcal infection.M...
Get full text
Article -
10
Principles of organization of medical care for patients with heart failure in the system of cardiovascular risk management: focus on continuity of care and patient routing. Practic... by S. V. Villevalde, A. E. Soloveva, N. E. Zvartau, N. G. Avdonina, A. N. Yakovlev, M. Yu. Sitnikova, P. A. Fedotov, Yu. M. Lopatin, A. S. Galyavich, D. V. Duplyakov, I. V. Fomin, E. V. Shlyakho
Published 2021-10-01The extent of the problem of heart failure determines the priority of the intention of developing and implementing an optimal model of medical care for this group of patients. The article describes the key components of the heart failure medical care (continuity, patient routing, educational activit...
Get full text
Article -
11
Relationships and Activities. The study is supported by OOO AstraZeneca Pharmaceuticals. by E. V. Shlyakhto, Yu. N. Belenkov, S. I. Boytsov, S. V. Villevalde, A. S. Galyavich, M. G. Glezer, N. E. Zvartau, Zh. Kobalava, Yu. M. Lopatin, Yu. V. Mareev, S. N. Tereshchenko, I. V. Fomin, O. L. Barbarash, N. G. Vinogradova, D. V. Duplyakov, I. V. Zhirov, E. D. Kosmacheva, V. A. Nevzorova, O. M. Reitblat, A. E. Soloveva, E. A. Zorina
Published 2023-07-01Heart failure (HF) is a global health problem. Despite advances in the development of effective treatments for patients with heart failure, morbidity and mortality from remain high, and the prognosis is poor. However, there is potential to improve outcomes in HF patients with current disease-modifyi...
Get full text
Article -
12
Interim analysis of a prospective observational multicenter registry study of patients with chronic heart failure in the Russian Federation "PRIORITET-CHF": initial characteristics... by E. V. Shlyakhto, Yu. N. Belenkov, S. A. Boytsov, S. V. Villevalde, A. S. Galyavich, N. G. Glezer, N. E. Zvartau, Zh. D. Kobalava, Yu. M. Lopatin, V. Yu. Mareev, S. N. Tereshchenko, I. V. Fomin, O. L. Barbarash, N. G. Vinogradova, D. V. Duplyakov, I. V. Zhirov, E. D. Kosmacheva, V. A. Nevzorova, O. M. Reitblat, A. E. Solovieva, E. A. Zorina
Published 2023-11-01Aim. To describe demographic and clinical laboratory characteristics, concomitant diseases and drug therapy of outpatients with heart failure (HF) in the Russian Federation.Material and methods. An interim analysis of a prospective observational multicenter registry study of patients with chronic he...
Get full text
Article -
13
Implemented models and elements for heart failure care in the regions of the Russian Federation: prospects for transformation into regional cardiovascular risk management systems by E. V. Shlyakhto, N. E. Zvartau, S. V. Villevalde, A. N. Yakovlev, A. E. Soloveva, N. G. Avdonina, E. A. Medvedeva, G. V. Endubaeva, V. A. Karlina, A. E. Solovev, A. A. Fedorenko, V. V. Zaitsev, S. A. Panarina, A. M. Erastov, N. G. Vinogradova, I. V. Fomin, N. P. Rogozina, Zh. A. Shlosberg, O. M. Moiseeva, M. Yu. Sitnikova
Published 2020-05-01The high and growing incidence and mortality of patients with heart failure (HF) should receive priority attention when developing an action plan to reduce cardiovascular mortality in the Russian Federation. The article provides an analysis of the implemented elements of HF care in 40 Russian region...
Get full text
Article -
14
Empagliflozin in patients hospitalized for acute decompensated heart failure: an expert resolution on the discussion of the EMPULSE trial by Yu. M. Lopatin, G. P. Arutyunov, A. S. Ametov, F. T. Ageev, M. B. Antsiferov, O. L. Barbarash, S. V. Villevalde, N. G. Vinogradova, G. R. Galstyan, A. S. Galyavich, S. R. Gilyarevsky, M. G. Glezer, I. V. Zhirov, M. V. Ilyin, A. Yu. Lebedeva, S. V. Nedogoda, V. V. Salukhov, E. I. Tarlovskaya, S. N. Tereshchenko, I. V. Fomin, Yu. Sh. Khalimov, D. V. Cherkashin
Published 2022-04-01An online expert meeting held on November 17, 2021 reviewed the results of the randomized, double-blind, multinational, parallel-group EMPULSE trial, evaluating the clinical benefit and safety of the sodium-glucose co-transporter-2 inhibitor (SGLT2i) empagliflozin compared with placebo in patients h...
Get full text
Article -
15
Approaches to the therapy of heart failure with reduced ejection fraction. Resolution of an online meeting of the Volga Federal District experts by A. S. Galyavich, I. V. Fomin, I. R. Gaisin, F. V. Valeeva, N. G. Vinogradova, A. S. Salasyuk, E. I. Tarlovskaya, N. R. Khasanov, A. M. Shutov, E. N. Volodina, L. V. Grekhova, P. S. Guseva, D. V. Duplyakov, O. V. Zanozina, Yu. V. Zolotova, S. V. Kanysheva, Z. F. Kim, S. K. Kononov, V. P. Kuzmin, S. S. Markiyanova, M. V. Menzorov, S. A. Pomosov, A. P. Rebrov, S. N. Tolstov
Published 2022-02-01At an online meeting of experts held on May 14, 2021 additional research results on a sodium-glucose co-transporter-2 (SGLT2) inhibitor empagliflozin in patients with heart failure with reduced ejection fraction were considered. According to the data from the EMPEROR-Reduced international study, car...
Get full text
Article -
16
Comparative analysis of echocardiographic and electrocardiographic data of survivors and deceased patients with COVID-19 (sub-analysis of the international register “Dynamics analy... by G. P. Arutyunov, E. I. Tarlovskaya, A. G. Arutyunov, Y. N. Belenkov, A. O. Konradi, Y. M. Lopatin, A. P. Rebrov, S. N. Tereshchenko, A. I. Chesnikova, A. R. Vaisberg, N. Y. Grigorieva, B. B. Ogurlieva, I. V. Fomin, I. A. Frolova, O. Yu. Badina, O. E. Vilkova, N. V. Zarechnova, N. A. Kamardina, E. V. Koroleva, K. V. Mazalov, D. V. Soloveva
Published 2022-04-01Aim. To carry out comparative analysis of echocardiographic and electrocardiographic (ECG) data of survivors and deceased patients with COVID-19 (sub-analysis of the international register “Dynamics analysis of comorbidities in SARS-CoV-2 survivors”).Material and methods. The study presents the resu...
Get full text
Article -
17
Resolution of an online meeting of the Volga Federal District experts on the EMPEROR-Reduced trial “A new era in the treatment of patients with HF. From EMPA-REG OUTCOME to EMPEROR... by S. V. Villevalde, A. S. Galyavich, N. G. Vinogradova, E. N. Volodina, I. R. Gaisin, S. R. Gilyarevsky, L. V. Grekhova, Yu. A. Guryanova, P. S. Guseva, D. V. Duplyakov, A. V. Ezhov, N. E. Zakirova, Yu. V. Zolotova, A. V. Isakov, S. V. Kanysheva, Z. F. Kim, V. P. Kuzmin, S. S. Markiyanova, S. A. Pomosov, A. P. Rebrov, E. I. Tarlovskaya, S. N. Tolstov, I. V. Fomin, N. R. Khasanov, A. M. Shutov
Published 2021-07-01An online meeting of experts held on November 6, 2020 describes the results of EMPA-REG OUTCOME and EMPEROR-Reduced trials on sodium-glucose co-transporter-2 (SGLT2) inhibitor empagliflozin. We analyzed cardiovascular and renal outcomes in patients with and without type 2 diabetes (T2D) receiving em...
Get full text
Article -
18
Pericarditis. Clinical Guidelines 2022 by G. P. Arutyunov, F. N. Paleev, E. I. Tarlovskaya, O. M. Moiseeva, A. G. Arutyunov, N. A. Koziolova, A. I. Chesnikova, A. P. Rebrov, I. I. Shaposhnik, M. M. Petrova, N. Yu. Grigorieva, I. V. Fomin, Ya. A. Orlova, S. V. Malchikova, L. Yu. Koroleva, V. P. Nosov, S. A. Ayvazyan, O. V. Zairatyants, V. E. Sinitsyn, Yu. A. Vasyuk, G. E. Gendlin, D. O. Dragunov, A. V. Sokolova, O. B. Irtyuga
Published 2023-04-01Russian Society of Cardiology (RSC)With the participation of the Eurasian Association of Therapists, the Russian Scientific Medical Society of Therapists (RNMOT), the Russian Society of Pathologists, the Russian Society of Radiologists and Radiologists (RSR)Approved by the Scientific and Practical C...
Get full text
Article -
19
Guidelines for the diagnosis and treatment of circulatory diseases in the context of the COVID-19 pandemic by E. V. Shlyakho, A. O. Konradi, G. P. Arutyunov, A. G. Arutyunov, A. E. Bautin, S. A. Boytsov, S. V. Villevalde, N. Yu. Grigoryeva, D. V. Duplyakov, N. E. Zvartau, N. A. Koziolova, D. S. Lebedev, S. V. Malchikova, E. A. Medvedeva, E. N. Mikhailov, O. M. Moiseeva, Ya. A. Orlova, T. V. Pavlova, D. V. Pevsner, M. M. Petrova, A. P. Rebrov, M. Yu. Sitnikova, A. E. Solovyova, E. I. Tarlovskaya, M. A. Trukshina, P. A. Fedotov, I. V. Fomin, A. V. Khripun, A. I. Chesnikova, I. I. Shaposhnik, I. S. Yavelov, A. N. Yakovlev
Published 2020-04-01Guidelines for the diagnosis and treatment of circulatory diseases in the context of the COVID-19 pandemic
Get full text
Article -
20
ACUTE ST ELEVATION MYOCARDIAL INFARCTION: AFTERCARE AND SECONDARY PREVENTION. NATIONAL RUSSIAN GUIDELINES by M. G. Bubnova, O. L. Barbarash, A. A. Doletsky, V. B. Krasnitsky, E. V. Lebedev, N. P. Lyamina, A. N. Repin, A. V. Light, G. A. Chumakov, D. M. Aronov, A. A. Abdullaev, T. P. Arutyunov, O. L. Barbarash, S. A. Boytsov, S. A. Boldueva, Yu. I. Buziashvili, A. S. Galyavich, A. A. Garganeeva, M. Yu. Gerasimenko, S. F. Gulyaeva, P. Ya. Dovgalevsky, A. I. Zhuravlev, V. S. Zadionchenko, V. P. Zaitsev, A. N. Zakirova, G. E. Ivanov, D. G. Iosseliani, A. M. Kalinina, R. S. Karpov, N. A. Kosilov, G. A. Kulikov, V. V. Kuharchuk, K. V. Lyadov, V. P. Mazaev, A. I. Martynov, O. F. Misyura, E. J. Parnes, N. B. Perepech, A. N. Repin, M. Ya. Ruda, I. I. Old Believers, A. B. Smulevich, A. L. Syrkin, S. N. Tereshchenko, I. V. Fomin, E. I. Chazov, I. E. Chazova, S. V. Shlyk, E. V. Shlyakhto, V. A. Shulman
Published 2015-01-01.
Get full text
Article